Multi-target MET tyrosine kinase inhibitors (TKIs) are a class of drugs ,designed to inhibit the MET receptor tyrosine kinase and other related or unrelated tyrosine kinases to block multiple signaling pathways involved in cancer progression.

The global Multi-target MET TKIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Multi-target MET TKIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Multi-target MET TKIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Multi-target MET TKIs include Pfizer, Exelixis, MSN Labs, Stada Arzneimittel, Teva, Cipla, BDR Pharma, Elemento Pharma, Beacon Pharmaceuticals, Wanbang Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Multi-target MET TKIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-target MET TKIs.

The Multi-target MET TKIs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Multi-target MET TKIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Multi-target MET TKIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Multi-target MET TKIs Market Report

Report Metric	Details
Report Name	Multi-target MET TKIs Market
Segment by Type	cabozantinib Crizotinib Other
Segment by Application	Non-small Cell Lung Cancer Medullary Thyroid Cancer Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Exelixis, MSN Labs, Stada Arzneimittel, Teva, Cipla, BDR Pharma, Elemento Pharma, Beacon Pharmaceuticals, Wanbang Biopharmaceuticals, Drug International, Genvio Pharma, Everest Pharmaceuticals, Zydus
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multi-target MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multi-target MET TKIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Multi-target MET TKIs Market report?

Ans: The main players in the Multi-target MET TKIs Market are Pfizer, Exelixis, MSN Labs, Stada Arzneimittel, Teva, Cipla, BDR Pharma, Elemento Pharma, Beacon Pharmaceuticals, Wanbang Biopharmaceuticals, Drug International, Genvio Pharma, Everest Pharmaceuticals, Zydus

What are the Application segmentation covered in the Multi-target MET TKIs Market report?

Ans: The Applications covered in the Multi-target MET TKIs Market report are Non-small Cell Lung Cancer, Medullary Thyroid Cancer, Other

What are the Type segmentation covered in the Multi-target MET TKIs Market report?

Ans: The Types covered in the Multi-target MET TKIs Market report are cabozantinib, Crizotinib, Other

1 Multi-target MET TKIs Market Overview

1.1 Product Definition

1.2 Multi-target MET TKIs by Type

1.2.1 Global Multi-target MET TKIs Market Value Comparison by Type (2024-2030)

1.2.2 cabozantinib

1.2.3 Crizotinib

1.2.4 Other

1.3 Multi-target MET TKIs by Application

1.3.1 Global Multi-target MET TKIs Market Value by Application (2024-2030)

1.3.2 Non-small Cell Lung Cancer

1.3.3 Medullary Thyroid Cancer

1.3.4 Other

1.4 Global Multi-target MET TKIs Market Size Estimates and Forecasts

1.4.1 Global Multi-target MET TKIs Revenue 2019-2030

1.4.2 Global Multi-target MET TKIs Sales 2019-2030

1.4.3 Global Multi-target MET TKIs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Multi-target MET TKIs Market Competition by Manufacturers

2.1 Global Multi-target MET TKIs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Multi-target MET TKIs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Multi-target MET TKIs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Multi-target MET TKIs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Multi-target MET TKIs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Multi-target MET TKIs, Product Type & Application

2.7 Global Key Manufacturers of Multi-target MET TKIs, Date of Enter into This Industry

2.8 Global Multi-target MET TKIs Market Competitive Situation and Trends

2.8.1 Global Multi-target MET TKIs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Multi-target MET TKIs Players Market Share by Revenue

2.8.3 Global Multi-target MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Multi-target MET TKIs Market Scenario by Region

3.1 Global Multi-target MET TKIs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Multi-target MET TKIs Sales by Region: 2019-2030

3.2.1 Global Multi-target MET TKIs Sales by Region: 2019-2024

3.2.2 Global Multi-target MET TKIs Sales by Region: 2025-2030

3.3 Global Multi-target MET TKIs Revenue by Region: 2019-2030

3.3.1 Global Multi-target MET TKIs Revenue by Region: 2019-2024

3.3.2 Global Multi-target MET TKIs Revenue by Region: 2025-2030

3.4 North America Multi-target MET TKIs Market Facts & Figures by Country

3.4.1 North America Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Multi-target MET TKIs Sales by Country (2019-2030)

3.4.3 North America Multi-target MET TKIs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Multi-target MET TKIs Market Facts & Figures by Country

3.5.1 Europe Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Multi-target MET TKIs Sales by Country (2019-2030)

3.5.3 Europe Multi-target MET TKIs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Multi-target MET TKIs Market Facts & Figures by Region

3.6.1 Asia Pacific Multi-target MET TKIs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Multi-target MET TKIs Sales by Region (2019-2030)

3.6.3 Asia Pacific Multi-target MET TKIs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Multi-target MET TKIs Market Facts & Figures by Country

3.7.1 Latin America Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Multi-target MET TKIs Sales by Country (2019-2030)

3.7.3 Latin America Multi-target MET TKIs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Multi-target MET TKIs Market Facts & Figures by Country

3.8.1 Middle East and Africa Multi-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Multi-target MET TKIs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Multi-target MET TKIs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Multi-target MET TKIs Sales by Type (2019-2030)

4.1.1 Global Multi-target MET TKIs Sales by Type (2019-2024)

4.1.2 Global Multi-target MET TKIs Sales by Type (2025-2030)

4.1.3 Global Multi-target MET TKIs Sales Market Share by Type (2019-2030)

4.2 Global Multi-target MET TKIs Revenue by Type (2019-2030)

4.2.1 Global Multi-target MET TKIs Revenue by Type (2019-2024)

4.2.2 Global Multi-target MET TKIs Revenue by Type (2025-2030)

4.2.3 Global Multi-target MET TKIs Revenue Market Share by Type (2019-2030)

4.3 Global Multi-target MET TKIs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Multi-target MET TKIs Sales by Application (2019-2030)

5.1.1 Global Multi-target MET TKIs Sales by Application (2019-2024)

5.1.2 Global Multi-target MET TKIs Sales by Application (2025-2030)

5.1.3 Global Multi-target MET TKIs Sales Market Share by Application (2019-2030)

5.2 Global Multi-target MET TKIs Revenue by Application (2019-2030)

5.2.1 Global Multi-target MET TKIs Revenue by Application (2019-2024)

5.2.2 Global Multi-target MET TKIs Revenue by Application (2025-2030)

5.2.3 Global Multi-target MET TKIs Revenue Market Share by Application (2019-2030)

5.3 Global Multi-target MET TKIs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Multi-target MET TKIs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Exelixis

6.2.1 Exelixis Company Information

6.2.2 Exelixis Description and Business Overview

6.2.3 Exelixis Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Exelixis Multi-target MET TKIs Product Portfolio

6.2.5 Exelixis Recent Developments/Updates

6.3 MSN Labs

6.3.1 MSN Labs Company Information

6.3.2 MSN Labs Description and Business Overview

6.3.3 MSN Labs Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 MSN Labs Multi-target MET TKIs Product Portfolio

6.3.5 MSN Labs Recent Developments/Updates

6.4 Stada Arzneimittel

6.4.1 Stada Arzneimittel Company Information

6.4.2 Stada Arzneimittel Description and Business Overview

6.4.3 Stada Arzneimittel Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Stada Arzneimittel Multi-target MET TKIs Product Portfolio

6.4.5 Stada Arzneimittel Recent Developments/Updates

6.5 Teva

6.5.1 Teva Company Information

6.5.2 Teva Description and Business Overview

6.5.3 Teva Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Teva Multi-target MET TKIs Product Portfolio

6.5.5 Teva Recent Developments/Updates

6.6 Cipla

6.6.1 Cipla Company Information

6.6.2 Cipla Description and Business Overview

6.6.3 Cipla Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Cipla Multi-target MET TKIs Product Portfolio

6.6.5 Cipla Recent Developments/Updates

6.7 BDR Pharma

6.7.1 BDR Pharma Company Information

6.7.2 BDR Pharma Description and Business Overview

6.7.3 BDR Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.7.4 BDR Pharma Multi-target MET TKIs Product Portfolio

6.7.5 BDR Pharma Recent Developments/Updates

6.8 Elemento Pharma

6.8.1 Elemento Pharma Company Information

6.8.2 Elemento Pharma Description and Business Overview

6.8.3 Elemento Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Elemento Pharma Multi-target MET TKIs Product Portfolio

6.8.5 Elemento Pharma Recent Developments/Updates

6.9 Beacon Pharmaceuticals

6.9.1 Beacon Pharmaceuticals Company Information

6.9.2 Beacon Pharmaceuticals Description and Business Overview

6.9.3 Beacon Pharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Beacon Pharmaceuticals Multi-target MET TKIs Product Portfolio

6.9.5 Beacon Pharmaceuticals Recent Developments/Updates

6.10 Wanbang Biopharmaceuticals

6.10.1 Wanbang Biopharmaceuticals Company Information

6.10.2 Wanbang Biopharmaceuticals Description and Business Overview

6.10.3 Wanbang Biopharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Wanbang Biopharmaceuticals Multi-target MET TKIs Product Portfolio

6.10.5 Wanbang Biopharmaceuticals Recent Developments/Updates

6.11 Drug International

6.11.1 Drug International Company Information

6.11.2 Drug International Description and Business Overview

6.11.3 Drug International Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Drug International Multi-target MET TKIs Product Portfolio

6.11.5 Drug International Recent Developments/Updates

6.12 Genvio Pharma

6.12.1 Genvio Pharma Company Information

6.12.2 Genvio Pharma Description and Business Overview

6.12.3 Genvio Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Genvio Pharma Multi-target MET TKIs Product Portfolio

6.12.5 Genvio Pharma Recent Developments/Updates

6.13 Everest Pharmaceuticals

6.13.1 Everest Pharmaceuticals Company Information

6.13.2 Everest Pharmaceuticals Description and Business Overview

6.13.3 Everest Pharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Everest Pharmaceuticals Multi-target MET TKIs Product Portfolio

6.13.5 Everest Pharmaceuticals Recent Developments/Updates

6.14 Zydus

6.14.1 Zydus Company Information

6.14.2 Zydus Description and Business Overview

6.14.3 Zydus Multi-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Zydus Multi-target MET TKIs Product Portfolio

6.14.5 Zydus Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Multi-target MET TKIs Industry Chain Analysis

7.2 Multi-target MET TKIs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Multi-target MET TKIs Production Mode & Process

7.4 Multi-target MET TKIs Sales and Marketing

7.4.1 Multi-target MET TKIs Sales Channels

7.4.2 Multi-target MET TKIs Distributors

7.5 Multi-target MET TKIs Customers

8 Multi-target MET TKIs Market Dynamics

8.1 Multi-target MET TKIs Industry Trends

8.2 Multi-target MET TKIs Market Drivers

8.3 Multi-target MET TKIs Market Challenges

8.4 Multi-target MET TKIs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Beacon Pharmaceuticals

Wanbang Biopharmaceuticals

Drug International

Genvio Pharma

Everest Pharmaceuticals

Zydus

BDR Pharma

List of Tables

Table 1. Global Multi-target MET TKIs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Multi-target MET TKIs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Multi-target MET TKIs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Multi-target MET TKIs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Multi-target MET TKIs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Multi-target MET TKIs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Multi-target MET TKIs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Multi-target MET TKIs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Multi-target MET TKIs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Multi-target MET TKIs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Multi-target MET TKIs, Product Type & Application

Table 12. Global Key Manufacturers of Multi-target MET TKIs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Multi-target MET TKIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-target MET TKIs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Multi-target MET TKIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Multi-target MET TKIs Sales by Region (2019-2024) & (K Units)

Table 18. Global Multi-target MET TKIs Sales Market Share by Region (2019-2024)

Table 19. Global Multi-target MET TKIs Sales by Region (2025-2030) & (K Units)

Table 20. Global Multi-target MET TKIs Sales Market Share by Region (2025-2030)

Table 21. Global Multi-target MET TKIs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Multi-target MET TKIs Revenue Market Share by Region (2019-2024)

Table 23. Global Multi-target MET TKIs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Multi-target MET TKIs Revenue Market Share by Region (2025-2030)

Table 25. North America Multi-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Multi-target MET TKIs Sales by Country (2019-2024) & (K Units)

Table 27. North America Multi-target MET TKIs Sales by Country (2025-2030) & (K Units)

Table 28. North America Multi-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Multi-target MET TKIs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Multi-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Multi-target MET TKIs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Multi-target MET TKIs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Multi-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Multi-target MET TKIs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Multi-target MET TKIs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Multi-target MET TKIs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Multi-target MET TKIs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Multi-target MET TKIs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Multi-target MET TKIs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Multi-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Multi-target MET TKIs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Multi-target MET TKIs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Multi-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Multi-target MET TKIs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Multi-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Multi-target MET TKIs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Multi-target MET TKIs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Multi-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Multi-target MET TKIs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Multi-target MET TKIs Sales (K Units) by Type (2019-2024)

Table 51. Global Multi-target MET TKIs Sales (K Units) by Type (2025-2030)

Table 52. Global Multi-target MET TKIs Sales Market Share by Type (2019-2024)

Table 53. Global Multi-target MET TKIs Sales Market Share by Type (2025-2030)

Table 54. Global Multi-target MET TKIs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Multi-target MET TKIs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Multi-target MET TKIs Revenue Market Share by Type (2019-2024)

Table 57. Global Multi-target MET TKIs Revenue Market Share by Type (2025-2030)

Table 58. Global Multi-target MET TKIs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Multi-target MET TKIs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Multi-target MET TKIs Sales (K Units) by Application (2019-2024)

Table 61. Global Multi-target MET TKIs Sales (K Units) by Application (2025-2030)

Table 62. Global Multi-target MET TKIs Sales Market Share by Application (2019-2024)

Table 63. Global Multi-target MET TKIs Sales Market Share by Application (2025-2030)

Table 64. Global Multi-target MET TKIs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Multi-target MET TKIs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Multi-target MET TKIs Revenue Market Share by Application (2019-2024)

Table 67. Global Multi-target MET TKIs Revenue Market Share by Application (2025-2030)

Table 68. Global Multi-target MET TKIs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Multi-target MET TKIs Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Multi-target MET TKIs Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Exelixis Company Information

Table 76. Exelixis Description and Business Overview

Table 77. Exelixis Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Exelixis Multi-target MET TKIs Product

Table 79. Exelixis Recent Developments/Updates

Table 80. MSN Labs Company Information

Table 81. MSN Labs Description and Business Overview

Table 82. MSN Labs Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. MSN Labs Multi-target MET TKIs Product

Table 84. MSN Labs Recent Developments/Updates

Table 85. Stada Arzneimittel Company Information

Table 86. Stada Arzneimittel Description and Business Overview

Table 87. Stada Arzneimittel Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Stada Arzneimittel Multi-target MET TKIs Product

Table 89. Stada Arzneimittel Recent Developments/Updates

Table 90. Teva Company Information

Table 91. Teva Description and Business Overview

Table 92. Teva Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Teva Multi-target MET TKIs Product

Table 94. Teva Recent Developments/Updates

Table 95. Cipla Company Information

Table 96. Cipla Description and Business Overview

Table 97. Cipla Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Cipla Multi-target MET TKIs Product

Table 99. Cipla Recent Developments/Updates

Table 100. BDR Pharma Company Information

Table 101. BDR Pharma Description and Business Overview

Table 102. BDR Pharma Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. BDR Pharma Multi-target MET TKIs Product

Table 104. BDR Pharma Recent Developments/Updates

Table 105. Elemento Pharma Company Information

Table 106. Elemento Pharma Description and Business Overview

Table 107. Elemento Pharma Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Elemento Pharma Multi-target MET TKIs Product

Table 109. Elemento Pharma Recent Developments/Updates

Table 110. Beacon Pharmaceuticals Company Information

Table 111. Beacon Pharmaceuticals Description and Business Overview

Table 112. Beacon Pharmaceuticals Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Beacon Pharmaceuticals Multi-target MET TKIs Product

Table 114. Beacon Pharmaceuticals Recent Developments/Updates

Table 115. Wanbang Biopharmaceuticals Company Information

Table 116. Wanbang Biopharmaceuticals Description and Business Overview

Table 117. Wanbang Biopharmaceuticals Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Wanbang Biopharmaceuticals Multi-target MET TKIs Product

Table 119. Wanbang Biopharmaceuticals Recent Developments/Updates

Table 120. Drug International Company Information

Table 121. Drug International Description and Business Overview

Table 122. Drug International Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Drug International Multi-target MET TKIs Product

Table 124. Drug International Recent Developments/Updates

Table 125. Genvio Pharma Company Information

Table 126. Genvio Pharma Description and Business Overview

Table 127. Genvio Pharma Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Genvio Pharma Multi-target MET TKIs Product

Table 129. Genvio Pharma Recent Developments/Updates

Table 130. Everest Pharmaceuticals Company Information

Table 131. Everest Pharmaceuticals Description and Business Overview

Table 132. Everest Pharmaceuticals Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Everest Pharmaceuticals Multi-target MET TKIs Product

Table 134. Everest Pharmaceuticals Recent Developments/Updates

Table 135. Zydus Company Information

Table 136. Zydus Description and Business Overview

Table 137. Zydus Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Zydus Multi-target MET TKIs Product

Table 139. Zydus Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Multi-target MET TKIs Distributors List

Table 143. Multi-target MET TKIs Customers List

Table 144. Multi-target MET TKIs Market Trends

Table 145. Multi-target MET TKIs Market Drivers

Table 146. Multi-target MET TKIs Market Challenges

Table 147. Multi-target MET TKIs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Multi-target MET TKIs

Figure 2. Global Multi-target MET TKIs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Multi-target MET TKIs Market Share by Type: 2023 & 2030

Figure 4. cabozantinib Product Picture

Figure 5. Crizotinib Product Picture

Figure 6. Other Product Picture

Figure 7. Global Multi-target MET TKIs Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Multi-target MET TKIs Market Share by Application: 2023 & 2030

Figure 9. Non-small Cell Lung Cancer

Figure 10. Medullary Thyroid Cancer

Figure 11. Other

Figure 12. Global Multi-target MET TKIs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Multi-target MET TKIs Market Size (2019-2030) & (US$ Million)

Figure 14. Global Multi-target MET TKIs Sales (2019-2030) & (K Units)

Figure 15. Global Multi-target MET TKIs Average Price (US$/Unit) & (2019-2030)

Figure 16. Multi-target MET TKIs Report Years Considered

Figure 17. Multi-target MET TKIs Sales Share by Manufacturers in 2023

Figure 18. Global Multi-target MET TKIs Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Multi-target MET TKIs Players: Market Share by Revenue in Multi-target MET TKIs in 2023

Figure 20. Multi-target MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Multi-target MET TKIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Multi-target MET TKIs Sales Market Share by Country (2019-2030)

Figure 23. North America Multi-target MET TKIs Revenue Market Share by Country (2019-2030)

Figure 24. United States Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Multi-target MET TKIs Sales Market Share by Country (2019-2030)

Figure 27. Europe Multi-target MET TKIs Revenue Market Share by Country (2019-2030)

Figure 28. Germany Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Multi-target MET TKIs Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Multi-target MET TKIs Revenue Market Share by Region (2019-2030)

Figure 35. China Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Multi-target MET TKIs Sales Market Share by Country (2019-2030)

Figure 43. Mexico Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Multi-target MET TKIs Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Multi-target MET TKIs Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Multi-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Multi-target MET TKIs by Type (2019-2030)

Figure 53. Global Revenue Market Share of Multi-target MET TKIs by Type (2019-2030)

Figure 54. Global Multi-target MET TKIs Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Multi-target MET TKIs by Application (2019-2030)

Figure 56. Global Revenue Market Share of Multi-target MET TKIs by Application (2019-2030)

Figure 57. Global Multi-target MET TKIs Price (US$/Unit) by Application (2019-2030)

Figure 58. Multi-target MET TKIs Value Chain

Figure 59. Multi-target MET TKIs Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microwave Tumor Ablation System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22N12035

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Carbon Fiber Radiotherapy Table Top and Headrest Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1S13226

Thu Aug 29 00:00:00 UTC 2024

Add to Cart

Global Multi-target MET TKIs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9X18229

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global MET TKIs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32L18018

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions